UCB : Closing of the sale of Methylamines & Derivatives Activities
Brussels, Belgium, September 30, 2003 - UCB confirms the sale of its Methylamines & Derivatives business to the company formed by NIB Capital Private Equity N.V., as already announced early August. All these activities grouped together in a separate business unit under the name "Taminco", were part of Surface Specialties.
Closing of the transaction took place on September 30, 2003. As mentioned before, the transaction amount is € 115 million.
|Business media and investor relations enquiries|
Tel : +32-(0)2-559.92.64
E-mail : email@example.com
Stay up-to-date on the latest news and information from UCB